Use of recombinant human thyroid stimulating hormone (rhTSH) in therapy of differentiated thyroid carcinoma (DTC) with Iodine-131(I-131), in patients (pts) already treated after T4 withdrawal.

被引：0
|
作者：
Ferreira, TC [1 ]
Sevilla, A [1 ]
Garrao, A [1 ]
Henriques, M [1 ]
Limbert, E [1 ]
Vieira, MR [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S467 / S467
页数：1
相关论文
共 50 条
  • [21] Clearance of 131I after recombinant human thyrotropin (rhTSH) compared to hypothyroidism in athyreotic patients with treated differentiated thyroid cancer.
    McDougall, IR
    Weigel, RJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 323P - 323P
  • [22] Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131
    Rosario, Pedro W. S.
    Borges, Michelle A. R.
    Costa, Graaela B. C.
    Rezende, Leonardo L.
    Padrao, Eduardo L.
    Barroso, Alvaro L.
    Purisch, Saulo
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (01) : 99 - 103
  • [23] Recombinant human thyrotropin for Iodine-131 therapy in management of differentiated thyroid carcinoma: A single center case series from Pakistan
    Khan, M. U.
    Nawaz, M. K.
    Afzal, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S197 - S197
  • [24] 124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone vs thyroid hormone withdrawal patient preparation methods
    Plyku, Donika
    Hobbs, Robert
    Huang, Kevin
    Atkins, Frank
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [25] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer
    Plyku, Donika
    Hobbs, Robert F.
    Huang, Kevin
    Atkins, Frank
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1146 - 1154
  • [26] Thyroid hormone withdrawal versus recombinant human TSH administration in radio-iodine therapy of thyroid cancer: comparison of I-131 effective half-life
    Perisinakis, K.
    Donas, C.
    Dimitraki, A.
    Koukouraki, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S394 - S395
  • [27] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Yusuke Iizuka
    Tomohiro Katagiri
    Kengo Ogura
    Minoru Inoue
    Ryota Nakashima
    Kiyonao Nakamura
    Takashi Mizowaki
    Scientific Reports, 13
  • [28] Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
    Iizuka, Yusuke
    Katagiri, Tomohiro
    Ogura, Kengo
    Inoue, Minoru
    Nakashima, Ryota
    Nakamura, Kiyonao
    Mizowaki, Takashi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis
    Giovanella, Luca
    Garo, Maria Luisa
    Campenni, Alfredo
    Ovcaricek, Petra Petranovic
    Goerges, Rainer
    CANCERS, 2023, 15 (09)
  • [30] Iodine kinetics during I-131 scanning in patients with thyroid cancer: Comparison of studies with recombinant human TSH (RHTSH) vs hypothyroidism.
    Park, SG
    Reynolds, JC
    BruckerDavis, F
    Whatley, M
    McEllin, K
    Maxted, D
    Robbins, J
    Weintraub, BD
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 49 - 49
12345